{"id":"W2000322328","doi":"10.6000/1927-7229.2013.02.03.4","title":"Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Capecitabine; Irinotecan; Medicine; Colorectal cancer; Oncology; Internal medicine; Schedule; Chemotherapy; Cancer; Computer science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001396754,0.0001931489,0.0009839272,0.0002359249,0.00006282142,0.000006087786,0.00007246887,0.00005044427,0.0001931218],"category_scores_gemma":[0.0001627134,0.0001020208,0.00007413646,0.0003429769,0.0001140533,0.0001021583,0.00001727074,0.0002015474,8.516466e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005772251,"about_ca_system_score_gemma":0.0004598784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001731451,"about_ca_topic_score_gemma":0.002819743,"domain_scores_codex":[0.9985535,0.00004294354,0.0006041798,0.0001904923,0.0003794035,0.0002295528],"domain_scores_gemma":[0.9980728,0.0003044843,0.0004569637,0.00008894849,0.0009365448,0.0001402593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3932544,0.2591766,0.09765427,0.0002367509,0.005321098,0.000446366,0.003890708,0.001511625,0.000271476,0.0001321357,0.0006127429,0.2374919],"study_design_scores_gemma":[0.1505413,0.7355805,0.1092664,0.0002479897,0.0007229729,0.00002943269,0.001138583,0.001584275,0.0002578063,0.00005711898,0.0004380221,0.0001356134],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941308,0.00004885692,0.000108856,0.003734115,0.00005648024,0.001751502,0.000009056447,0.000004248505,0.0001560162],"genre_scores_gemma":[0.9981777,0.00005616692,0.001111908,0.0002668048,0.00003771204,0.000159256,0.00000426166,0.00001982457,0.0001663799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4764039,"threshold_uncertainty_score":0.4160286,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02150949824874921,"score_gpt":0.3563468603706982,"score_spread":0.334837362121949,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}